Cargando…
Calciphylaxis in a dialysis patient successfully treated with high-dose vitamin K supplementation
Calciphylaxis has high mortality. Vitamin K deficiency is common in haemodialysis patients and may be a trigger for calciphylaxis due to its role in activating matrix Gla protein (a tissue inhibitor of calcification). We report the case of a 43-year-old female haemodialysis patient who developed cal...
Autores principales: | Christiadi, Daniel, Singer, Richard F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070075/ https://www.ncbi.nlm.nih.gov/pubmed/30094016 http://dx.doi.org/10.1093/ckj/sfx126 |
Ejemplares similares
-
Placebo-controlled, randomized clinical trial of high-dose cholecalciferol in renal dialysis patients: effect on muscle strength and quality of life
por: Singer, Richard, et al.
Publicado: (2018) -
The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials
por: Caluwé, Rogier, et al.
Publicado: (2016) -
Multimodal treatment of calcific uraemic arteriolopathy (calciphylaxis): a case series
por: Russo, Domenico, et al.
Publicado: (2016) -
Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients
por: Fouque, Denis, et al.
Publicado: (2018) -
Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice: Mimosa study
por: Rottembourg, Jacques, et al.
Publicado: (2019)